Small Pharma
Pipeline of novel patent-protected deuterium-enriched tryptamine compounds for psychedelic-assisted psychotherapy as a rapid onset, sustained treatment for mental health disorders.
Launch date
Employees
Market cap
AUD57.1m
Enterprise valuation
AUD43m (Public information from Oct 2023)
Share price
CAD0.15 DMT.V
Company register number 09420724
London England (HQ & founding location)
Authorizing premium user...